Table 1.
IGM Treatment Consensus – results from second and third round voting
| Round 2, % | Round 3, % | Consensus, yes/no | |||
|---|---|---|---|---|---|
| agree | disagree | agree | disagree | ||
| OBS (±drainage) is the appropriate treatment for Type 2 cases | 52 | 48 | 55 | 45 | No |
| ILS is the appropriate treatment for Type 2 cases | 66 | 34 | 76 | 24 | No |
| TOPS is the appropriate treatment for Type 2 cases | 60 | 40 | 71 | 29 | No |
| SS is the appropriate treatment for Type 2 cases | 24 | 76 | 46 | 54 | No |
| ILS is the appropriate treatment for Type 3 cases | 37 | 63 | No | ||
| SS is the appropriate treatment for Type 3 cases | 84 | 16 | Yes | ||
| IMT is the appropriate treatment for Type 3 cases | 37 | 63 | No | ||
| COMB is the appropriate treatment for Type 3 cases | 66 | 34 | No | ||
| In treating recurrent (Type 4) cases, reclassification based on the IGM-TCC is essential for treatment planning | 94 | 6 | Yes | ||
| IMT is the appropriate treatment for resistant (Type 4) cases | 60 | 40 | No | ||
| COMB is the appropriate treatment for resistant (Type 4) cases | 82 | 18 | Yes | ||
| In Type 3 cases, IMT can be administered if SS are contraindicated | 81 | 19 | Yes | ||
| In resistant Type 4 cases, IMT is a viable treatment option | 93 | 7 | Yes | ||
| Surgery plays a role in the treatment of IGM. | 74 | 26 | No | ||
| In Type 3 and Type 4 cases, SURG can be considered to remove residual disease following systemic therapy | 67 | 33 | No | ||
| SURG is an option for patients with disease relapse following previous treatment and reclassification as Type 1 or Type 2 | 45 | 55 | No | ||
| SURG should not be considered the first treatment option for Type 1 or Type 2 cases | 81 | 19 | Yes | ||
| The follow-up interval during treatment should be scheduled every 15 days | 23 | 77 | No | ||
| The follow-up interval during treatment should be scheduled every month | 61 | 39 | No | ||
| The follow-up interval during treatment should be scheduled every 1.5–2 months | 22 | 78 | No | ||
| Physical examination and breast ultrasonography should be performed at each follow-up during treatment | 51 | 49 | No | ||
| Treatment should only be discontinued upon achieving a CCR, confirmed by both physical examination and radiological assessment | 81 | 19 | Yes | ||
Bold text indicates a consensus.
OBS, observation; ILS, intralesional steroid; TOPS, topical steroid; SS, systemic steroid; IMT, immunosuppressive therapy; COMB, combination therapy; IGM-TCC, IGM-Turkish Clinical Classification; SURG, surgical excision; CCR, complete clinical response.